Unknown

Dataset Information

Growth hormone treatment in the pre-transplant period is associated with superior outcome after pediatric kidney transplantation.


ABSTRACT:

Background

Recombinant human growth hormone (rhGH) is frequently used for treatment of short stature in children with chronic kidney disease (CKD) prior to kidney transplantation (KT). To what extent this influences growth and transplant function after KT is yet unknown.

Methods

Post-transplant growth (height, sitting height, leg length) and clinical parameters of 146 CKD patients undergoing KT before the age of 8 years, from two German pediatric nephrology centers, were prospectively investigated with a mean follow-up of 5.56 years. Outcome in patients with (rhGH group) and without (non-prior rhGH group) prior rhGH treatment was assessed by the use of linear mixed-effects models.

Results

Patients in the rhGH group spent longer time on dialysis and less frequently und

SUBMITTER: Jagodzinski C 

PROVIDER: S-EPMC8960657 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature